reviewBMJNov 9, 2020GREEN OA

Treatment of epithelial ovarian cancer

Washington University in St. Louis · University of Colorado Denver

PubMed
Indexed incrossrefpubmed

Abstract

Ovarian cancer is the third most common gynecologic malignancy worldwide but accounts for the highest mortality rate among these cancers. A stepwise approach to assessment, diagnosis, and treatment is vital to appropriate management of this disease process. An integrated approach with gynecologic oncologists as well as medical oncologists, pathologists, and radiologists is of paramount importance to improving outcomes. Surgical cytoreduction to R0 is the mainstay of treatment, followed by adjuvant chemotherapy. Genetic testing for gene mutations that affect treatment is the standard of care for all women with epithelial ovarian cancer. Nearly all women will have a recurrence, and the treatment of recurrent…

Citation impact

908
total citations
FWCI
86.67
Percentile
100%
References
134
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Bevacizumab
  • Ovarian cancer
  • Disease
  • Oncology
  • Cancer
  • Internal medicine
  • Malignancy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.